Login / Signup

Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials.

Young Sang LyuSangmo HongSi Eun LeeBo Young ChoCheol Young Park
Published in: Cardiovascular diabetology (2024)
Not applicable (pooled analysis).
Keyphrases
  • randomized controlled trial
  • study protocol
  • phase iii
  • cell therapy
  • open label